C. Lai

发表

Benzoxazole benzenesulfonamides as allosteric inhibitors of fructose-1,6-bisphosphatase.

C. Abad-Zapatero, R. Gum, C. Hutchins, 2006, Bioorganic & medicinal chemistry letters.

Efficient preparation of S-aryl thioacetates from aryl halides and potassium thioacetate

B. J. Backes, C. Lai, 2007 .

Investigation of biaryl heterocycles as inhibitors of Wee1 kinase.

K. Bromberg, Eric F. Johnson, N. Soni, 2019, Bioorganic & medicinal chemistry letters.

Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit.

G. L. Hamilton, K. Longenecker, H. Sham, 2007, Bioorganic & medicinal chemistry letters.

Synthesis, activity, metabolic stability, and pharmacokinetics of glucocorticoid receptor modulator-statin hybrids.

M. Emery, S. Fung, Jiahong Wang, 2004, Bioorganic & medicinal chemistry letters.

Discovery and structure-activity relationships of piperidinone- and piperidine-constrained phenethylamines as novel, potent, and selective dipeptidyl peptidase IV inhibitors.

K. Longenecker, H. Sham, Xiaofen Li, 2007, Journal of medicinal chemistry.

Benzoxazole benzenesulfonamides as allosteric inhibitors of fructose-1,6-bisphosphatase.

C. Abad-Zapatero, R. Gum, C. Hutchins, 2006, Bioorganic & medicinal chemistry letters.

Aminopyrimidinone cdc7 kinase inhibitors.

Eric F. Johnson, N. Soni, J. Miyashiro, 2012, Bioorganic & medicinal chemistry letters.

Nonracemic homopropargylic alcohols via asymmetric allenylboration with the robust and versatile 10-TMS-9-borabicyclo[3.3.2]decanes.

J. Soderquist, C. Lai, 2005, Organic letters.

Discovery of a Potent and Selective Covalent p300/CBP Inhibitor.

Mikkel A. Algire, Chaohong Sun, K. Bromberg, 2021, ACS medicinal chemistry letters.

Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 Inhibitors.

K. Longenecker, T. Penning, Y. Tong, 2021, ACS medicinal chemistry letters.

Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes.

K. Koehler, L. Hagberg, C. Jakob, 2004, Journal of medicinal chemistry.

Benzoxazole benzenesulfonamides are novel allosteric inhibitors of fructose-1,6-bisphosphatase with a distinct binding mode.

Celerino Abad-Zapatero, Chaohong Sun, C. Abad-Zapatero, 2006, Bioorganic & medicinal chemistry letters.